2Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diag- nosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Rcspir Crit Care Med, 2007,176(6) :532-555. 被引量：1
3Global Initiative for COPD(GOLD). Global strategy for the diagno- sis, management, and prevention of chronic obstructive pulmonary disease[ EB/OL]. www. goldcopd, org. 2006. 被引量：1
2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989. 被引量：1
3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946. 被引量：1
4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012. 被引量：1
7Global Initiative for Chronic Obstructive Lung Disease. Global Strat- egy for the diagnosis, management, and prevention of chronic ob- structive pulmonary disease ( updated 2009). www. goldcopd, com. 被引量：1
8Mannino DM, Buist AS. Global burden of COPD:risk factors,preva- lence, and future trends. Lancet,2007,370 (9589) :765-773. 被引量：1
9Frey U, Makkonen K, Wellman T, et al. Alterations in airway wallproperties in infants with a history of wheezing disorders [J]. Am JRespir Crit Care Med, 2000, 161(6): 1825-1829. 被引量：1
